RT

Reach Tone

Description

Reach Tone

Investor Profile

Reach Tone has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series D rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Health Diagnostics.

Stage Focus

  • Series D (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Health Diagnostics
  • Hospital
  • Precision Medicine
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Reach Tone frequently co-invest with?

Genomic Health
North America, California, United States, Redwood City
Co-Investments: 1
HC
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Sabby Capital
North America, New Jersey, United States, Upper Saddle River
Co-Investments: 1
Domain Associates
North America, California, United States, San Diego
Co-Investments: 1
RMI Partners
Europe, Moscow City, Russian Federation, Moscow
Co-Investments: 1
AC
North America, California, United States, Los Altos
Co-Investments: 1
Pagoda Investment
Asia, Beijing, China, Beijing
Co-Investments: 1
V
North America, California, United States, San Mateo
Co-Investments: 1

What are some of recent deals done by Reach Tone?

Epic Sciences

La Jolla, California, United States

Epic Sciences is a diagnostics company improving cancer management by providing real-time biopsy material to guide personalized medicine.

BiotechnologyHealth CareHealth DiagnosticsHospitalPrecision Medicine
Series DApr 28, 2017
Amount Raised: $40,000,000